Press Releases Faron Pharmaceuticals Oy

Equities

Market Closed - London S.E. Other stock markets 11:35:02 2024-06-20 EDT			5-day change	1st Jan Change
98 ^GBX	+5.95%		+3.16%	-67.87%

06-06	Transcript : Faron Pharmaceuticals Oy - Shareholder/Analyst Call
06-04	Faron Pharmaceuticals to Launch EUR31 Million Share Offering	MT

New shares registered with Finnish Trade Register	06-20	AQ
Inside Information: Faron publishes the final result of the fully subscribed EUR 30.7 million share offering	06-20	AQ
Proposed REX Retail Offer	06-05	AQ
Faron commences a share offering	06-04	AQ
Faron Pharmaceuticals Oy - Issuance of warrants	05-20	AQ
Initial positive data from Phase 2 of BEXMAB	05-20	AQ
Issuance of warrants	05-17	AQ
Faron Founders and bexmarilimab Developers Selected as Finalists for the European Inventor Award 2024	05-16	AQ
Founders named European Inventor Award finalists	05-16	AQ
Replacement - Board Change	05-13	AQ
Faron Pharmaceuticals' new CEO Dr Juho Jalkanen sets bold vision for 2024	05-08	AQ
Update on financial status	04-30	AQ
Board Change	04-30	AQ
Faron Pharmaceuticals Oy - Insider Information, Appointment of Chief Financial Officer	04-16	AQ
Faron confirms plans under new leadership	04-16	AQ
Faron Confirms Plans for the Coming Months Under New Leadership	04-16	AQ
Appointment of Chief Financial Officer	04-15	AQ
Approval of Warrant Terms and Conditions	04-08	AQ
Decisions of the Board of Directors	04-08	AQ
Appointment of Chief Executive Officer	04-08	AQ

No results for this search